Article
Circulating Tumor DNA Profiling of Advanced Biliary Tract Cancers
18 Mar 2019
Abstract excerpt
PURPOSE Recent advances in molecular diagnostic technologies have allowed for the evaluation of solid tumor malignancies via noninvasive blood sampling, including circulating tumor DNA (ctDNA) profiling. We sought to characterize the ctDNA genomic alteration landscape in patients with biliary tract cancers (BTCs). PATIENTS AND METHODS From January 2015 to February 2018, 124 patients with BTC at the Mayo Clinic...
Topics
Join the communities discussing this publication.
